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Different protein complexes form on newly spliced
mRNA to ensure the accuracy and efficiency of eu-
karyotic gene expression. For example, the exon junc-
tion complex (EJC) plays an important role in mRNA
surveillance. The EJC also influences the first, or pio-
neer round of protein synthesis through a mechanism
that is poorly understood. We show that the nutrient-,
stress-, and energy-sensing checkpoint kinase,
mTOR, contributes to the observed enhanced transla-
tion efficiency of spliced over nonspliced mRNAs. We
demonstrate that, when activated, S6K1 is recruited to
the newly synthesized mRNA by SKAR, which is de-
posited at the EJC during splicing, and that SKAR
and S6K1 increase the translation efficiency of spliced
mRNA. Thus, SKAR-mediated recruitment of acti-
vated S6K1 to newly processed mRNPs serves as
a conduit between mTOR checkpoint signaling and
the pioneer round of translation when cells exist in
conditions supportive of protein synthesis.
INTRODUCTION
In higher eukaryotes, most protein-coding genes are interrupted
by introns. In the nucleus, splicing machinery removes introns
from nascent pre-mRNA transcripts before the mRNAs are ex-
ported to the cytoplasm for translation. In addition to creating
translatable mRNAs, splicing also facilitates later events in
mRNA metabolism, including export, subcellular localization,
mRNA surveillance, and protein synthesis (reviewed in Reed
and Cheng, 2005; Le Hir et al., 2003; Lejeune and Maquat,
2005; Wilkinson, 2005).
The act of splicing ‘‘imprints’’ mRNA with a special set of
proteins, which are multisubunit complexes including the TREX
complex and the exon-junction complex (EJC) (reviewed in
Tange et al., 2004; Reed and Cheng, 2005). The major nuclear
cap-binding heterodimer CBP80/20 (major components of the
cap binding complex or CBC) binds to the 50 cap of pre-mRNA
cotranscriptionally and is also required for efficient splicing
(Izaurralde et al., 1994). Splicing recruits the TREX components,
such as UAP56 and Aly/REF, to spliced mRNA near the CBP80/20-bound cap and facilitates mRNA export (Cheng et al., 2006).
Splicing also recruits the EJC, which is formed 20 nucleotides
(nts) upstream of each exon-exon junction on spliced mRNA (Le
Hir et al., 2000). Like CBP80/20, the EJC proteins are nucleocy-
toplasmic shuttling proteins that remain bound to mRNA after
the mRNA-protein (mRNP) complex is exported to the cytoplasm
(Kataoka et al., 2000; Dostie and Dreyfuss, 2002). Consistently,
nuclear and cytoplasmic CBP80-bound mRNPs coimmunopre-
cipitate the EJC proteins (Ishigaki et al., 2001; Lejeune et al.,
2002). The removal of EJCs from mRNA occurs after the first
passage of ribosomes, a process known as the ‘‘pioneer’’ round
of translation (Ishigaki et al., 2001; Wang et al., 2001; Dostie and
Dreyfuss, 2002; Lejeune et al., 2002). During or after the pioneer
round of translation, CBP80/20 is replaced by the major cyto-
plasmic cap-binding protein eIF4E (Ishigaki et al., 2001; Lejeune
et al., 2002; Chiu et al., 2004).
The EJC functions to eliminate mRNAs with premature termi-
nation codons (PTCs), a process known as mRNA surveillance
(reviewed in Lejeune and Maquat, 2005), and enhances protein
synthesis of normal mRNAs (Wiegand et al., 2003; Nott et al.,
2004; Gudikote et al., 2005). The stable core of the EJC contains
four proteins: eukaryotic initiation factor 4AIII (eIF4AIII), Magoh,
Y14, and MLN51 (also known as Barentsz), while other EJC
proteins associate peripherally with the heterotetrameric core
(reviewed in Tange et al., 2004). The peripheral EJC proteins
identified so far include splicing coactivators (SRm160, RNPS1,
and Pinin), mRNA surveillance factors (Upf3a, Upf3b, and Upf2),
and some recently identified factors with unknown function
(Acinus and SAP18) (reviewed in Tange et al., 2004; Chang
et al., 2007). When a PTC occurs > 50-55 nts upstream of an
exon-exon junction, the pioneer round of translation does not
remove the EJCs downstream of the PTC, which ultimately trig-
gers nonsense-mediated decay (NMD) of the mRNA (reviewed in
Lejeune and Maquat, 2005).
Following the pioneer round of translation, mRNAs bound with
eIF4E undergo steady-state translation. The rate-limiting step in
the process of protein synthesis is translation initiation (reviewed
in Gingras et al., 1999). Critical to this, eIF4E recruits eIF3 and the
40S ribosomal subunit to the 50 end of mRNA. Several of the ini-
tiation steps are regulated by the mammalian target-of-rapa-
mycin complex 1 (mTORC1). mTORC1 signaling, a positive reg-
ulator of protein synthesis which can be inhibited by rapamycin,
is responsive to cellular energy status, nutrient availability, stress
and the presence of growth factors. Under cellular conditionsCell 133, 303–313, April 18, 2008 ª2008 Elsevier Inc. 303
supportive of protein synthesis, mTORC1 signaling to its major
downstream effectors is initiated by its binding to eIF3 and the
translation preinitiation complex where hypophosphorylated
eIF4E binding proteins (4E-BPs) and the 40S ribosomal subunit
protein S6 (rpS6) protein kinases (S6Ks) reside. Recruitment of
mTORC1 into proximity of 4EBP1 leads to its phosphorylation
and dissociation from eIF4E, resulting in the recruitment of the
scaffold protein eIF4G, the RNA helicase eIF4A and poly(A)-
associated poly(A)-binding protein PABP1 into the translation
preinitiation complex (Gingras et al., 2001; reviewed in Hay and
Sonenberg, 2004). mTORC1 binding to eIF3 also results in phos-
phorylation and dissociation of S6K1. Once activated, S6K1
phosphorylates rpS6 and eIF4B (reviewed in Fingar and Blenis,
2004). Phosphorylated eIF4B is recruited to eIF4A in the transla-
tion preinitiation complex (Holz et al., 2005). Finally, S6K1 also
phosphorylates the tumor suppressor, PDCD4, an inhibitor of
eIF4A. This phosphorylation event results in recruitment of the
E3 ubiquitin ligase, bTRCP, leading to ubiquitination and degra-
dation of PDCD4 (Dorrello et al., 2006). The S6K1 coordinated
phosphorylation and recruitment of eIF4B to eIF4A and phos-
phorylation and degradation of PDCD4 is thought to greatly
enhance eIF4A helicase activity, which facilitates 40S ribosomal
subunit scanning to the initiation codon (Methot et al., 1996).
It has long been known that the presence of one or more
introns in a gene, and therefore splicing, enhances gene expres-
sion (Callis et al., 1987; Palmiter et al., 1991; Braddock et al.,
1994; Matsumoto et al., 1998; Lu and Cullen, 2003). EJC depo-
sition is sufficient and necessary for a splicing-dependent in-
crease in gene expression, potentially by enhancing association
of spliced mRNAs with polysomes (Wiegand et al., 2003; Nott
et al., 2004). Moreover, efficient splicing strongly promotes
translation, which leads to an enhanced NMD response if
a PTC is present in a gene (Gudikote et al., 2005). This suggests
that efficient splicing may have evolved to enhance both steady-
state translation and the pioneer round of translation through
splicing-dependent formation of the EJC. Despite these recent
advances in our understanding of the function of the EJC, the
molecular mechanisms by which the EJC enhances protein
synthesis remain poorly understood.
While much has been learned about the regulatory mecha-
nisms of steady-state translation, it is unclear whether or how
the pioneer round of translation of newly spliced mRNAs is reg-
ulated. This is due at least in part to the fact that the pioneer
initiation complex is different from the steady-state initiation
complex. Dynamic mRNP remodeling occurs during or after
translation of CBP80-bound mRNAs so that the EJC proteins
are undetectable in the eIF4E-bound mRNPs (Ishigaki et al.,
2001; Lejeune et al., 2002; Chiu et al., 2004). However, the
CBP80-bound mRNPs contain some components that also
function during steady-state translation initiation, such as eIF4G,
eIF4A, eIF2a, and eIF3 (Ishigaki et al., 2001; Lejeune et al., 2002,
2004; Chiu et al., 2004), suggesting that the assembly of the
pioneer initiation complex could also be a rate-limiting step
when translation machinery encounters newly spliced mRNAs.
Based on the above description of the important regulatory
functions associated with the splicing-dependent assembly of
the EJC and the role of the EJC in mRNA quality control and
enhanced translational yield, we hypothesized that this process304 Cell 133, 303–313, April 18, 2008 ª2008 Elsevier Inc.must be carefully monitored and regulated in the cell. Since
protein synthesis is exquisitely sensitive to nutrient availability,
energy status, stress responses and growth stimuli, we investi-
gated the possible link between mTOR signaling, which is
precisely regulated under these various conditions, and splic-
ing-modulated protein synthesis.
Consistent with our hypothesis, we found that rapamycin in-
hibited the increase in translation efficiency gained by splicing.
This finding suggested the possibility that mTOR and S6K1 might
contribute to the assembly of an efficient pioneer initiation com-
plex on CBP80-bound mRNA in response to environmental
cues. Since the formation of the EJC is tightly linked to this pro-
cess, we then asked if the EJC was somehow coupling mTOR
signaling to this process. We show that an S6K1 specific interac-
tor SKAR (S6K1 Aly/REF-like substrate), a cell growth regulator
of unknown function (Richardson et al., 2004), is associated
with CBP80-bound mRNP in a splicing-dependent manner.
Mapping of the SKAR binding site on mRNA localizes SKAR to
the EJC. Knockdown of SKAR or the core EJC component,
eIF4AIII, results in a decrease of activated S6K1 associated
with CBP80-bound mRNP and a reduction in the phosphorylation
of the mRNP associated proteins. Finally, knockdown of S6K1,
SKAR, and eIF4AIII leads to a similar decrease in the translation
efficiency of spliced mRNAs. Our data show that the EJC serves
an important function in linking mTOR signaling to the function of
the pioneer initiation complex, that the S6K1 interactor, SKAR, is
a component of the EJC, and that mTOR/S6K1 signaling contrib-
utes to the enhanced translation efficiency gained by splicing.
RESULTS
Linking mTOR Signaling to Protein Phosphorylation
of CBP80-Bound mRNPs
Considering that an efficient translation initiation complex
formed on newly spliced mRNAs is critical for the pioneer round
of translation, we investigated whether the mTOR pathway mod-
ifies components of CBC-mRNPs by regulating their phosphor-
ylation. We immunopurified CBC-mRNPs from serum-starved,
insulin-stimulated, or rapamycin-pretreated HEK293E cells us-
ing anti-CBP80 antibody. The immunocomplexes were resolved
by SDS-PAGE, and potential mTOR/S6K1 pathway targets in
these complexes were identified by western blot using a motif
antibody which recognizes a consensus sequence found in
many of Akt or S6K1 substrates: phospho-Ser/Thr preceded
by Lys/Arg at positions 5 and 3 (RXRXXpS/T). As shown in
Figure 1A, a number of phosphoproteins associated with
CBP80-bound mRNPs appeared with insulin stimulation, and
most of these phosphorylation events were rapamycin sensitive.
This suggests that the phosphorylation of these proteins is
regulated by the mTOR pathway.
To support a role for mTOR/S6K1 signaling in pioneer transla-
tion initiation, we examined the presence of mTOR and S6K1 in
CBP80-bound mRNPs. To this end, HEK293E cells were tran-
siently transfected with HA-tagged CBP80, and mRNPs were
immunoprecipitated using anti-HA antibody and, in parallel,
anti-eIF4E antibody. Since the eIF3 complex acts as a scaffold
for mTOR and S6K1 binding during translation initiation (Holz
et al., 2005), proteins coimmunoprecipitated with the eIF3b
subunit served as controls. As shown in Figure 1B, mTOR was
found to be enriched in both CBP80 and eIF4E immunocom-
plexes following insulin stimulation. Following phosphorylation
and dissociation from the eIF3 complex, there was a reduction
in the amount of activated S6K1 associated with eIF4E-bound
mRNPs upon insulin stimulation. Surprisingly though, activated
S6K1 remained bound to CBP80-bound mRNPs suggesting
a potentially unique connection between activated S6K1 and
the regulation of the pioneer round of translation.
SKAR Is Preferentially Associated with CBP80-Bound
mRNPs
Since hyperphosphorylated S6K1 is found in CBP80-bound
mRNPs, we hypothesized that S6K1 interacting proteins in the
mRNP may serve to bring S6K1 near its translational targets after
S6K1 is activated and dissociated from the eIF3 complex. S6K1
would then be able to phosphorylate these proximally associated
proteins in the CBC-mRNP complex. Previous studies identified
SKAR, an S6K1 interacting protein with unknown function (Ri-
chardson et al., 2004). Importantly, SKAR selectively interacts
with activated S6K1 and not S6K2 (Richardson et al., 2004). Thus
it is possible that SKAR may serve to recruit S6K1 to CBC-mRNPs.
We first wanted to determine whether SKAR interacts with
CBC-bound mRNPs or eIF4E-bound mRNPs. Interestingly,
SKAR was preferentially coprecipitated with HA-CBP80 but
not eIF4E (Figure 2A). Upf3b, an EJC factor found exclusively
in CBP80-bound mRNPs (Ishigaki et al., 2001), served as a
positive control. We also confirmed SKAR interaction with
Figure 1. Rapamycin-Sensitive mTOR/S6K1 Signaling on
CBP80-Bound mRNPs
(A) Phosphorylation of putative S6K1 substrates in CBP80-bound mRNPs.
CBP80-bound mRNPs were immunoprecipitated (IP) using anti-CBP80
antibody from cells treated as indicated. The phosphorylation of putative
S6K1 substrates was determined by immunoblotting with anti-RXRXXpS/
T motif antibody. Immunoblotting with anti-phospho-S6 (Ser 240/244)
antibody was performed to confirm the recognition of phospho-S6 by
the motif antibody. Potential S6K1 substrates were indicated with arrow-
heads.
(B) Activated S6K1 and mTOR interact with CBP80-bound mRNPs.
HEK293E cells were transfected with HA-tagged CBP80. Forty-eight
hours posttransfection, the eIF3 complex, and mRNPs associated with
HA-CBP80 or eIF4E were immunoprecipitated as described and their
interaction with mTOR and S6K1 determined by immunoblotting. Normal
rabbit serum (NRS) was used as a negative control in the experiments.
These data are representative of greater than three experiments. Note
that due to differences in the amount of eIF3 in the eIF3b IPs versus the
HA-CBP80 and eIF4E IPs, thus resulting in differences in exposure times,
the eIF3b immunoblots have been spliced together.
endogenous CBP80-bound mRNPs. As shown, anti-SKAR
antibody coimmunoprecipitated endogenous CBP80, but
not eIF4E (Figure 2B). These data suggest that SKAR pre-
ferentially associates with CBP80 or CBP80-bound mRNPs.
SKAR Is Associated with Spliced mRNPs
To understand if SKAR facilitates S6K1 functioning during the
pioneer round of translation, we set out to investigate the
molecular nature of the interaction between SKAR and
CBP80-bound mRNPs. SKAR is primarily localized to the nu-
cleus (Richardson et al., 2004). SKAR also exhibits a punctate
staining pattern that resembles that of nuclear speckles, from
which splicing factors are recruited to sites of transcription and
splicing. To test this possibility, we performed double immuno-
fluorescent staining of SKAR and splicing factor SC35, a molec-
ular marker for nuclear speckles. As shown in Figure 3A, SKAR
significantly colocalizes with SC35, suggesting that a function
of SKAR in the nucleus might be related to splicing and mRNP
biogenesis.
To determine if SKAR is linked to splicing and mRNP biogen-
esis, we asked if SKAR associates with spliceosomes and/or
spliced mRNPs. We employed a well-established method cou-
pling in vitro spliceosome assembly and affinity purification
(Zhou et al., 2002; Jurica et al., 2002). We introduced HA-
SKAR into cells, from which whole cell splicing extract was
prepared (Kataoka and Dreyfuss, 2004). Spliceosomes were as-
sembled by incubating the extract with 32P-labeled adenovirus
major late (AdML) pre-mRNA (Figure 3B). The pre-mRNA sub-
strate bears MS2-binding sequences at the 30 end, which serve
as a purification tag when pre-incubated with MS2-MBP fusion
protein. Spliceosomes were then affinity-selected by binding to
amylose resin and eluted with maltose-containing buffers.
MS2-tagged intronless AdML mRNA served as a negative con-
trol (Figure 3B). The RNA contents of the eluted products were
separated on a denaturing urea-PAGE. As visualized by phos-
phorimager analysis, spliced mRNAs were accumulated after
incubation, indicating that spliceosomes as well as mRNPsCell 133, 303–313, April 18, 2008 ª2008 Elsevier Inc. 305
generated through splicing were affinity purified (Figure 3C, left
panel). The protein contents of the eluted products were sub-
jected to SDS-PAGE and western blotting. As expected, splicing
factor SC35 was detected in purified spliceosomes but much
less so in the control purification (Figure 3C, right panel), indicat-
ing that the spliceosomes were highly purified. We then exam-
ined whether SKAR was enriched in the purified spliceosomes
and spliced mRNPs. As shown, SKAR also preferentially copuri-
fied with eluted spliceosomes and spliced mRNPs, and not with
the intronless RNA control, suggesting that SKAR is associated
with spliceosomes and/or spliced mRNPs, and that SKAR
exhibits little nonspecific RNA binding activity despite the fact
that it contains a highly conserved RNA recognition motif
(RRM) (Richardson et al., 2004). To avoid potential complications
resulting from high overexpression, HA-SKAR was expressed at
levels below that of endogenous SKAR (Figure 3D).
Having detected SKAR in spliceosomes and/or spliced
mRNPs, we wanted to further examine its binding to unspliced
pre-mRNAs versus spliced mRNAs. For this purpose, endoge-
nous SKAR was immunoprecipitated following in vitro splicing
reactions and the RNA content of the precipitant was resolved
by denaturing urea-PAGE to analyze the RNA species associ-
ated with SKAR. Remarkably, only spliced mRNAs coimmuno-
precipitated with SKAR (Figure 3E), suggesting that SKAR
preferentially associates with spliced mRNAs but not unspliced
pre-mRNAs or intronless control mRNAs. Since Aly/REF is re-
cruited to mRNA in a splicing-dependent manner (Cheng et al.,
2006), its association with spliced mRNAs served as a positive
control in this experiment. To test if the interaction between
SKAR and the spliced mRNA is substrate-independent, Fushi
tarazu (Ftz) pre-mRNA was used as an alternative substrate in
the RNA coimmunoprecipitation analysis described above.
Spliced Ftz mRNA was selectively coprecipitated by SKAR
Figure 2. SKAR Is Preferentially Associated with CBP80-Bound
mRNPs
(A) Immunoprecipitated CBP80-bound mRNPs contain SKAR. HEK293E cells
were cotransfected with Flag-Upf3b and HA-CBP80. Twenty-four hours post-
transfection, CBP80 and eIF4E mRNPs were immunoprecipitated. The associ-
ation of SKAR and Flag-Upf3b with CBP80-bound mRNPs was determined by
immunoblotting.
(B) SKAR coimmunoprecipitates endogenous CBP80. SKAR was immunopre-
cipitated and assayed for interaction with endogenous CBP80.306 Cell 133, 303–313, April 18, 2008 ª2008 Elsevier Inc.antibodies (Figure 3F). To examine whether SKAR recruitment
to spliced mRNA is regulated by the mTOR pathway, splicing
extracts were prepared from serum-starved, insulin-stimulated,
or rapamycin-pretreated and insulin-stimulated HEK293E cells.
However, no obvious difference on either splicing activity or
mRNA binding efficiency of SKAR was observed (data not
shown). These data, together with the finding that SKAR associ-
ates with CBP80-bound mRNP in the cell, indicate that SKAR is
recruited to newly generated mRNPs in a splicing-dependent,
substrate-independent manner.
SKAR Is Associated with the EJC
To gain further evidence for a possible role of SKAR in the pio-
neer round of translation, we next aimed to determine if SKAR
is recruited to the EJC. Since the EJC binds tightly to a short se-
quence 20 nts upstream of the exon-exon junction of spliced
mRNAs, RNase digestion applied after the in vitro splicing reac-
tion yields a short RNA oligonucleotide protected by the EJC (Le
Hir et al., 2000). This EJC-bound RNA oligonucleotide was then
subjected to coimmunoprecipitation analysis described in Fig-
ure 3E. To increase the sensitivity and specificity of this assay,
we introduced a single 32P-labeled nucleotide located 20 nt up-
stream of the 50 splice site to AdML pre-mRNA substrate as pre-
viously described (Le Hir et al., 2000; Ma et al., 2003). Intronless
AdML mRNA labeled at the equivalent position served as con-
trol. To ensure that the EJC-protected fragment was generated
properly as a result of splicing, in vitro splicing reactions at differ-
ent time points were treated with RNase A. As shown Figure 4A,
the amounts of EJC-protected fragments (right panel) were pro-
portional to spliced AdML mRNAs accumulated in the reactions
(left panel), whereas the intronless control mRNAs did not yield
any protected fragment following incubation under the same
splicing conditions (Le Hir et al., 2000). This result confirmed
that the RNA fragments specifically protected and bound by
the EJC were successfully generated following splicing and
RNase digestion. As shown in Figure 4B, the EJC-bound RNA
fragment was coimmunoprecipitated by anti-SKAR antibody.
As a negative control, antibodies against Aly/REF, a component
of the TREX complex that binds near the 50 end of spliced mRNA
(Cheng et al., 2006), failed to coprecipitate the EJC-protected
fragment. Antibodies against eIF4AIII, a core component of the
EJC, were used as a positive control. We also tested whether
SKAR interacts with EJC components in a similar RNase-resis-
tant manner. As shown in Figure 4C, eIF4AIII was coimmunopre-
cipitated with SKAR, and the interaction was not disrupted by
RNase digestion. Taken together, these results suggest that
SKAR is associated with the EJC.
SKAR Shuttles between the Nucleus and Cytoplasm
To further characterize SKAR, we also wanted to determine if
SKAR shuttles between the nucleus and cytoplasm. We em-
ployed a heterokaryon shuttling assay to test this possibility.
Briefly, plasmids expressing HA-SKAR and GFP-tagged hnRNP
C1, a non-shuttling factor serving as a negative control, were
transiently cotransfected into human U2OS cells, which were
then fused to non-transfected mouse NIH 3T3 cells to generate
heterokaryons. Four hours after cell fusion, cells were stained
with anti-HA antibodies to monitor the presence of HA-SKAR
Figure 3. SKAR Is Preferentially Associated
with Spliced mRNPs
(A) SKAR is concentrated in nuclear speckles.
U2OS or HeLa cells were fixed and costained for
SKAR (panels a and d), or HA-SKAR (g), and for
SC35 to localize nuclear speckles (b, e, and h). A
merge of the two images is shown with yellow
indicating areas of colocalization (c, f, and i).
(B) Schematic of AdML pre-mRNA and intronless
RNA control. MS2 is a bacteriophage protein,
which recognizes the MS2 tag shown at the 30
end of RNAs.
(C) SKAR copurifies with spliceosomes and/or
spliced mRNPs. Left panel: Total RNAs from the
initial splicing reaction (input), or eluted fractions
from the amylose affinity resin (elution) were sepa-
rated by 8% denaturing PAGE and visualized by
phosphorimager analysis. Uniformly 32P-labeled
AdML pre-mRNA and spliced mRNA (spliced),
and intronless mRNA (control) are indicated. Right
panel: Immunoblotting of the initial splicing reac-
tion (input), or eluted fractions (elution) using the
indicated antibodies. These data are representa-
tive of greater than three experiments.
(D) The ratio between HA-SKAR and endogenous
SKAR was shown by immunoblotting with anti-
SKAR antibodies.
(E) SKAR is preferentially associated with spliced
mRNA. Uniformly 32P-labeled AdML pre-mRNA
(lane 5) and intronless mRNA (lane 1) were both
incubated for 90 min under splicing conditions,
followed by immunoprecipitation with indicated
antibodies. One-tenth of total reaction was loaded
as input. RNAs were separated by 15% denaturing
PAGE. Structures of splicing substrates, interme-
diates and products are diagrammed. These
data are representative of greater than five exper-
iments.
(F) Splicing reaction and immunoprecipitation
were carried out as described in (E) except that
uniformly 32P-labeled Ftz pre-mRNA was used as
splicing substrate.in mouse nuclei. Human and mouse nuclei can easily be distin-
guished using DAPI staining, which appears speckled only in
mouse nuclei (Figure 4D, right panel). As shown, HA-SKAR
was detectable in the nuclei of mouse cells that have fused
with human cells and not in mouse cells that have not undergone
fusion (left panel). This data suggest that SKAR is a nucleocyto-
plasmic shuttling protein.
Effect of S6K1, SKAR, and eIF4AIII Knockdown on
Putative S6K1 Targets in CBP80-Bound mRNPs
We wanted to test the hypothesis that the association of acti-
vated S6K1 with the pioneer initiation complex was needed for
subsequent phosphorylation of CBP80-associated, mRNA bind-
ing proteins, and that SKAR may serve as a scaffold protein
for recruitment of activated S6K1 to the newly spliced mRNA.
To do this, we performed the phosphoprotein profiling analysis
using the anti-RXRXXpS/T motif antibody as described inFigure 1A. To avoid contamination from antibodies used for
immunoprecipitation, we introduced pNTAP vector expressing
CBP80 with streptavidin binding peptide (SBP) and calmodulin
binding peptide epitope tags into HEK293E cells and purified
the associated mRNPs. As shown in Figure 5A (right panel),
CBP80-bound mRNPs from S6K1 knockdown cells revealed re-
duced insulin-stimulated protein phosphorylation at RXRXXpS/T
sites compared to the control knockdown cells, suggesting that
many of these rapamycin-sensitive phosphoproteins, revealed
by this phospho-specific motif antibody, were indeed targets
of S6K1. Importantly, RNAi-mediated knockdown of SKAR
also prevented the insulin-stimulated increase of the same phos-
phoproteins in CBP80-bound mRNPs (similar results were
obtained with anti-HA-CBP80 immunoprecipitations, data not
shown). Moreover, knockdown of S6K2, a homolog of S6K1,
which does not interact with SKAR (Richardson et al., 2004),
did not affect S6K1-dependent phosphorylations (Figures S2ACell 133, 303–313, April 18, 2008 ª2008 Elsevier Inc. 307
Figure 4. SKAR Is Deposited on the EJC and Shuttles to the Cytoplasm
(A) Generating the EJC-protected fragments. Splicing time courses for AdML pre-mRNA containing a site-specific 32P label at 20 nt upstream of the 50 splice site
(left panel; lanes 2-6). ‘‘*’’ represents the site-specific 32P-label. ‘‘Con.’’ stands for control AdML mRNA was labeled at the equivalent position and incubated
under the same conditions for 90 min (left panel; lane 1). Complete RNase A digestion at each time point yielded the EJC-protected fragment of 19 nt in length
(right panel; lanes 4–6). RNA fragments were analyzed by a 20% denaturing PAGE.
(B) SKAR is associated with the EJC. The EJC-protected fragment was immunoprecipitated with the indicated antibodies. One-tenth of the input was loaded. The
RNA fragment with the site-specific 32P-label is illustrated. These data are representative of greater than three experiments.
(C) SKAR interacts with other components of the EJC in an RNase-resistant manner. SKAR was immunoprecipitated from cell lysates, and its interaction with
eIF4AIII was determined by immunoblotting. RNase A treatment was carried out at 20C for 20 min before adding antibody. CBP80 was used as the negative
control under conditions where RNase digestion was applied.
(D) SKAR is a nucleocytoplasmic shuttling protein. Heterokaryons were produced as described in Experimental Procedures. Cells were stained with DAPI (right)
and with anti-HA antibodies (left), while GFP-hnRNP C1 was directly visualized (middle). Arrowheads indicate mouse nuclei. A heterokaryon is shown by the arrow
on the left.308 Cell 133, 303–313, April 18, 2008 ª2008 Elsevier Inc.
and S2B). We also examined the association of activated S6K1
with CBP80-bound mRNPs in these cells. Following insulin stim-
ulation, the level of total and activated S6K1 in CBP80-bound
mRNPs was reduced in SKAR knockdown cells (Figure 5B),
which is consistent with the reduced level of phosphorylation
events in the mRNP. Knockdown of SKAR did not affect the
small amount of activated S6K1 associated with eIF4E-bound
mRNPs suggesting the possibility that S6K1 may also be re-
cruited to the translation apparatus in a SKAR-independent
mechanism, albeit at significantly lower levels (Figure 5B). We
also determined whether disrupting formation of the EJC has
a similar effect. The proper assembly of the EJC can be abol-
ished by eliminating one of its core components eIF4AIII (Shi-
buya et al., 2004). As expected, phosphorylation of proteins in
CBP80-bound mRNPs prepared from eIF4AIII knockdown cells
was also greatly reduced (Figure 5C). Taken together, these re-
sults suggest that an intact EJC and SKAR contribute signifi-
cantly to S6K1 phosphorylation of CBC-mRNPs.
S6K1, SKAR, and eIF4AIII Modulate Splicing-Dependent
Increase in Translational Efficiency
Since the EJC enhances translational yield of spliced mRNA
(Wiegand et al., 2003; Nott et al., 2004; Gudikote et al., 2005),
we examined whether mTOR signaling contributes to the splic-
ing-dependent increase in translational yield. HEK293E cells
were transiently transfected with two plasmids: (1) one of two
TPI/Renilla luciferase reporter constructs that encode either
intronless or intron-containing Renilla mRNA; and (2) the firefly
luciferase control plasmid (Figure 6A). The levels of firefly lucifer-
ase activity were used to control for variations in the efficiency of
cell transfection. Renilla luciferase activities were normalized to
corresponding firefly controls, and the ratio between intron-
containing and intronless renilla luciferase activities served as
an index for the enhanced translational yield gained by having
an intron (see Experimental Procedures). Using this assay, we
measured the effect of rapamycin on splicing-dependent in-
crease in protein synthesis. As shown in Figure 6B (upper panel),
rapamycin led to a significant decrease in intron-containing over
intronless translation rates suggesting that a splicing-dependent
increase in translation is modulated by mTOR signaling (similar
results were obtained in mouse embryonic fibroblasts, data not
shown). Semiquantitative RT-PCR analysis on intron-containing
renilla and Firefly mRNAs revealed no obvious difference be-
tween the treatment groups (right panel) and similar results
were observed for intronless renilla mRNAs (data not shown),
suggesting that changes in luciferase activity were due mainly
to changes in translational yield. To determine if S6K1, SKAR,
and eIF4AIII can modulate a splicing-dependent increase in
translational efficiency, we performed the luciferase reporter
assay as described above using cell lines with gene-specific
knockdowns. As shown in Figure 6C, knockdown of S6K1,
SKAR, and eIF4AIII all led to a significant decrease in transla-
tional efficiency of the spliced-message without evidently affect-
ing mRNA levels in these cells. Expression of an RNAi-immune
form of SKAR partially rescued the decrease in translational effi-
ciency due to knockdown of endogenous SKAR (Figure S3).
Moreover, knockdown of S6K2 did not affect the translational ef-
ficiency of the spliced-message (Figure S2C). Therefore, S6K1,the EJC, and SKAR positively modulate the translational yield
of intron-containing genes.
DISCUSSION
Under conditions of nutrient and energy sufficiency and the pres-
ence of growth factors that activate the mTOR pathway, the
translation initiation complex should be more efficient in the
translation of newly synthesized mRNAs. The enhanced effi-
ciency of translating new mRNAs gained by mTOR activation is
particularly important when a cell depends on production of spe-
cific effector proteins as a result of transcriptional activity in
response to a variety of stimuli. S6K1, through its association
with CBC-mRNPs may serve to ensure the efficiency and
accuracy of gene expression when the cell exists in conditions
supportive of protein synthesis.
The results reported in this study provide new information on
several levels. We provide data detailing the molecular mecha-
nism underlying splicing-dependent recruitment of SKAR, an
activated S6K1-specific interacting protein, to CBP80-bound
mRNPs. We have identified one binding site on the CBC-
mRNP to be at the EJC. Through SKAR the EJC serves to facil-
itate the association of S6K1 with CBP80-bound mRNPs and
to mediate subsequent phosphorylation events, potentially
contributing to efficient translation initiation and/or elongation.
Knockdown of SKAR or the EJC core component eIF4AIII leads
to dissociation of active S6K1 from the CBP80-bound mRNP,
loss of growth factor-stimulated, S6K1-mediated phosphoryla-
tions and a reduction of the translational yield gained by splicing.
Together, our data give insight into the molecular mechanism un-
derlying a splicing-dependent increase in translation efficiency
and provide a new paradigm for understanding protein synthesis
modulated by mTOR signaling.
How the EJC contributes to translation on newly synthesized
mRNAs is unclear. Our results suggest the following model for
how mTOR/S6K1 signaling contributes to enhanced translation
efficiency of spliced mRNPs. Following an activation signal
(e.g., insulin stimulation), mTOR/raptor is recruited to the eIF3
complex leading to phosphorylation of the bound and inactive
S6K1 at its hydrophobic motif, resulting in its dissociation.
PDK1 then binds S6K1 and phosphorylates its activation loop
site resulting in an activated kinase (Holz et al., 2005). The EJC
is required for splicing-dependent increase in protein synthesis
(Wiegand et al., 2003; Nott et al., 2004; Gudikote et al., 2005).
SKAR, which is located within the EJC, can then serve to recruit
activated S6K1 to the CBC-mRNP. In this way, activated S6K1 is
placed in proximity of additional translational targets, a process
that may contribute to the efficient assembly and activation of
the pioneer translation complex through S6K1-mediated phos-
phorylation events. Which proteins are phosphorylated and
how they function remains to be determined. By database anal-
ysis, several candidate targets with potential S6K1 phosphoryla-
tion sites are revealed including some previously identified
(reviewed in Hay and Sonenberg, 2004) that can be found in
various complexes along the CBC-mRNP. Interestingly, Y14,
a core component of the EJC was previously described to inter-
act with Aly/REF (Kataoka et al., 2001) and we have found that
SKAR interacts with Aly/REF in a two-hybrid screen usingCell 133, 303–313, April 18, 2008 ª2008 Elsevier Inc. 309
Figure 5. SKAR and eIF4AIII Mediate Phosphorylation of S6K1 Putative Targets in CBP80-Bound mRNPs
(A) Phosphorylation of putative S6K1 substrates in CBP80-bound mRNPs requires SKAR. HEK293E cells were infected with different shRNA-encoding viruses
to induce RNAi-mediated gene-specific knockdowns. Forty-eight hours postinfection, cells were transfected with SBP-CBP80 plasmid or empty vector as
control. Gene-specific knockdown was determined by immunoblotting with indicated antibodies, and the phosphorylation of putative S6K1 substrates in
cell lysates was determined by anti-RXRXXpS/T motif antibody (left panels). CBP80-bound mRNPs were affinity purified using streptavidin-conjugated resin,
and the phosphorylation of putative S6K1 substrates in the mRNPs was determined by anti-RXRXXpS/T motif antibody (right panel). Potential S6K1 substrates
were indicated with arrowheads. Immunoblotting with anti-phospho-S6 (Ser 240/244) antibody was used to confirm the recognition of phospho-S6 by the
motif antibody.
(B) The interaction between activated S6K1 and CBP80-bound mRNP is significantly reduced by RNAi depletion of SKAR. Gene specific knockdowns were
prepared as described in (A). Cells were then transfected with HA-CBP80 plasmid. Forty-eight hours posttransfection, CBP80 and eIF4E-associated mRNPs
were immunoprecipitated using anti-HA and anti-eIF4E antibodies, respectively. The presence of activated S6K1 in the mRNPs was determined by immuno-
blotting with the indicated antibodies.310 Cell 133, 303–313, April 18, 2008 ª2008 Elsevier Inc.
SKAR as bait (unpublished data). Aly/REF also bridges the TREX
complex to the 50 CBC (Cheng et al., 2006). Although the details
of these interactions have yet to be defined, these observations
suggest that the 50 CBC, the TREX complex, at least the first
EJC, and proteins associated with the polyA tail may be in prox-
imity to each other with the mRNA looping out between the var-
ious complexes. Thus activated S6K1 at the EJC may also be in
proximity with targets in the CBC, the TREX complex and the
polyA tail. Another possibility is that SKAR is also localized
through Aly/REF to the TREX complex again positioning S6K1
near additional targets. Having S6K1 localized to these com-
plexes provides the opportunity for S6K1 to phosphorylate
multiple proteins which contribute to translation initiation. In ad-
dition, S6K1 localized at EJCs may also allow it to contribute to
efficient translation elongation as the translational machinery
proceeds along the mRNP and encounters each EJC. Future
experiments are aimed at identifying the CBC-associated
S6K1 targets and testing the above hypotheses.
(C) Phosphorylation of putative S6K1 substrates in CBP80-bound mRNPs requires the EJC core protein eIF4AIII. RNAi-mediated knockdown of eIF4AIII,
affinity purification of CBP80-bound mRNPs and immunoblotting were performed as described in (A) and (B). Potential S6K1 substrates were indicated
with arrowheads.
Figure 6. S6K1, SKAR, and eIF4AIII Contribute to the
Enhanced Translational Yield Gained by Splicing
(A) Schematic of TPI/Renilla luciferase reporter constructs and
Firefly control construct (Nott et al., 2003, 2004). TPI: the sixth
intron and flanking exons from the human triose phosphate isom-
erase gene.
(B) Rapamycin antagonizes the enhanced translational yield
gained by splicing. HEK293E cells were transfected with reporter
constructs and serum starved. Forty-eight hours posttransfection,
cells were stimulated with insulin or pretreated with rapamycin and
stimulated with insulin for additional 4 or 16 hr. Luciferase activi-
ties were measured by a dual-luciferase assay. After normalization
to the cotransfected firefly control, the intron-containing/intron-
less Renilla luciferase light unit ratio was calculated as described
in Experimental Procedures. Experiments were carried out in trip-
licate. Data are presented as the mean ± SEM (left panel). mRNA
levels of Renilla and Firefly genes were monitored using semi-
quantitative RT-PCR analysis (right panel). PCR reactions without
reverse transcription (RT-) served as controls. A titration of RNA
quantity used in PCR reactions served to ensure the PCR reac-
tions were quantitative.
(C) S6K1, SKAR, and eIF4AIII modulate splicing-dependent
enhancement of translation. HEK293E cells with gene-specific
knockdowns were generated as in Figure 5. Cells were transfected
with the reporter constructs and serum starved. 48 hr posttrans-
fection, cells were stimulated with insulin. Luciferase activities
were measured and calculated. Data are presented as the
mean ± SEM (left panel). mRNA levels of Renilla and Firefly genes
were monitored using semiquantitative RT-PCR (right panel).
(D) Reduction of individual gene expression induced by shRNA-
mediated gene knockdown was determined by immunoblotting
with the indicated antibodies.
While the CBC, the TREX complex and EJCs are
removed from a newly synthesized mRNA during the
pioneer round of translation (Ishigaki et al., 2001),
how mTOR/S6K1 signaling are able to enhance overall
translational yield is a question yet to be addressed.
One possibility is that the first round of ribosome recruitment
to the mRNA may have a significant impact on the efficiency of
following rounds of ribosome recruitment. It is known that the ini-
tial ribosome recruitment is generally a rate-limiting step for
translation in vivo (reviewed in Sonenberg, 1996). Therefore, an
efficient pioneer initiation complex, mediated by the EJC and
the mTOR signaling pathway, may promote steady state transla-
tion efficiency, which leads to increased protein synthesis. An-
other possibility is that the efficiency of mRNP remodeling, which
occurs during or after the pioneer round of translation, may be
modulated by mTOR/S6K1 signaling. A major mRNP remodeling
event is the replacement of CBP80/20 by eIF4E at the 50 cap (Ish-
igaki et al., 2001). While eIF4E is a limiting factor for steady state
translation (reviewed in Sonenerg, 1996), its recruitment to the 50
cap during mRNP remodeling events may be critical for efficient
steady state translation. Thus, it will also be of interest to exam-
ine whether the mRNP remodeling as a result of the pioneer
round of translation is regulated by the mTOR signaling pathway.Cell 133, 303–313, April 18, 2008 ª2008 Elsevier Inc. 311
EXPERIMENTAL PROCEDURES
Plasmids
pRK7-HA-SKAR and pRK7-HA-CBP80 were constructed by cloning full-
length SKAR and CBP80, respectively, with an N-terminal hemagglutinin
(HA) tag into pRK7 plasmid. pNTAP-CBP80 was constructed by cloning
full-length CBP80 into pNTAP plasmid (Stratagene). The pSP72-AdML-M3,
pSP72-AdMLDi-M3 and pSP65-Ftz template constructs for in vitro transcrip-
tion and the MS2-MBP fusion protein construct were provided by Robin Reed
(Harvard Medical School, Boston, MA). Flag-tagged UPF3b and GFP-tagged
hnRNP C1 were provided by Joan Steitz (Yale University School of Medicine,
New Haven, CT). The TPI/Renilla and Firefly reporter constructs were provided
by Melissa Moore (Brandeis University, Waltham, MA) and were described
(Nott et al., 2003, 2004). Lentiviral plasmids (FSIPPW, D8.9, and VSVG) were
provided by Andrew L. Kung (Dana-Farber Cancer Institute, MA) and David
Baltimore (California Institute of Technology, CA).
Antibodies and Immunoblotting
Anti-SKAR antibodies were described previously (Richardson et al., 2004).
Anti-SC35 and anti-Flag antibodies were purchased from Sigma. Anti-HA
monoclonal antibodies were provided by Margaret Chou (University of
Pennsylvania, Philadelphia, PA). Anti-Aly, anti-CBP80, and anti-eIF4AIII were
generously provided by Robin Reed (Harvard Medical School, Boston, MA).
Anti-eIF3b, anti-mTOR, and anti-Actin antibodies were purchased from Santa
Cruz Biotechnology. Anti-S6K1, anti-S6, anti-phospho-S6 (Ser240/244),
anti-eIF4E, and anti-RXRXXpS/T motif antibodies were purchased from Cell
Signaling Technology. Proteins were resolved by SDS-PAGE, transferred
onto nitrocellulose (Schleicher and Schuell), and probed with indicated anti-
bodies. Data validating the specificity of antibodies used for immnoprecipita-
tions in this study were included in Figure S1 by showing western blotting of
a full-length gel.
Cell Lysis and mRNP Purification
Cell lysis and mRNP purification were performed according to Lejeune and
Maquat (2004), with minor modifications. HEK293E cells from four 15cm
dishes were lysed by sonication while suspended in 0.8mL of NET-2 (50 mM
Tris-HCl, [pH 7.4]; 300 mM NaCl; 0.05% NP-40; 1 mM sodium vanadate,
40 mg/mL phenylmethyl sulfonyl fluoride [PMSF]; 0.5 mg/mL Leupeptin;
5 mg/mL Pepstatin) containing 100 U of RNase-inhibitor (Ambion). Details on
antibody or affinity tag-based mRNP purification procedure were described
in Supplemental Data.
Cell Culture, Transfection, and Splicing Extract Preparation
HEK293E cells were cultured and transfected as described (Holz et al., 2005).
For experiments using starved, stimulated, and rapamycin treated conditions,
cells were starved for 24 hr in DMEM, then either left untreated, stimulated with
insulin (100 mM) for 30 min, or treated with rapamycin (20 ng/mL) for 20 min
prior to insulin addition. Whole cell extracts containing splicing activities
were prepared as described (Kataoka and Dreyfuss, 2004). For spliceosome
assembly and purification analysis, pRK7-HA-SKAR plasmid was transfected
into HEK293E cells twenty-four hours before splicing extracts were prepared.
For the rest of the splicing-related reactions, the extracts were prepared from
non-transfected HEK293E cells.
Spliceosome Assembly and Isolation
In vitro spliceosome assembly and affinity purification were performed accord-
ing to (Zhou et al., 2002; Jurica et al., 2002) with modifications. Pre-mRNA or
control mRNA (1.25 mg of each) containing MS2-binding sequences was incu-
bated on ice with 100 mg of MS2-MBP protein for 20min, followed by spliceo-
some assembly under conditions optimized for splicing (total volume 0.75 mL).
100 ml amylose resin was used to affinity purify spliceosomes. Experimental
details were described in Supplemental Data.
In Vitro Splicing and Immunoprecipitation
In vitro splicing reactions, analysis of splicing products, and immunoprecipita-
tions were performed according to Le Hir et al. (2000), with minor modifications
as described in Supplemental Data.312 Cell 133, 303–313, April 18, 2008 ª2008 Elsevier Inc.Construction of Site-Specific Radiolabeled RNA
AdML pre-mRNAs and control intronless mRNAs with site-specific radiolabel
were constructed according to Ma et al. (2003). Briefly, AdML RNAs were site-
specifically cleaved by RNase H in the presence of a specific 20-O-methyl
RNA-DNA chimeric oligonucleotide. 30 half was subjected to a dephosphoryla-
tion reaction and followed by rephosphorylation at its 50 end. The radiolabeled
30 half RNA was then re-ligated with the 50 half in the presence of a bridging
DNA oligonucleotide and T4 DNA ligase. Experimental details were described
in Supplemental Data.
Heterokaryon Assay and Immunofluorescence
The heterokaryon assay was performed according to (Pinol-Roma and Drey-
fuss, 1992) with minor modifications as described in Supplemental Data.
Luciferase Assay
HEK293E cells were split into two wells, named w1 and w2, respectively in a 6-
well plate. W1 was transfected with 0.5 mg of intron-containing TPI/Renilla
luciferase plasmid plus 50 ng of Firefly control, while w2 was transfected
with 0.5 mg intronless versions of TPI/Renilla luciferase plasmids plus 50 ng
of Firefly control. Twenty-four hours posttransfection, cells were treated as de-
scribed in different experiments, harvested, and the luciferase activity was
measured by Turner Designs TD-20/20 dual-channel luminometer and Dual-
Luciferase Reporter Assay System (Promega) according to the manufacturer’s
instructions. From w1 we obtained luciferase activities rw1 and fw1 represent-
ing Renilla luciferase and Firefly luciferase activities, respectively. Similarly,
from w2 we obtain rw2 and fw2, respectively. Then the ratio of the intron-con-
taining versus intronless TPI/Renilla gene expression was calculated by the
equation ratio = (rw1/fw1) / (rw2/fw2).
RNA Interference
RNA interference was performed using lentiviral short hairpin RNA (shRNA)
expression system as described in Supplemental Data.
RNA isolation and RT-PCR Analysis
RNA isolation and RT-PCR conditions and primer sequences were described
in Supplemental Data.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, Supple-
mental References, and three figures and can be found with this article online
at http://www.cell.com/cgi/content/full/133/2/303/DC1/.
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